Only a fool would rely on what the analyst say, its way to early in the RG-101 functional cure cycle as we have not even seen 12 week data let alone 48 week results a functional cure
Always do your own DD before investing a single penny in any stock
The stock is worth maybe $12 based on positive 12 week RG-101 data in June given the current biotech sector blues and the HepC landscape.
The EPS and projected store openings over next 3 years tell the whole story at $41 PPS
SELL THIS OVERPRICED BURGER PLAY SMELL THE TULIPS !!!!!!
Sentiment: Strong Sell
I know another Doctor who lies his name is Ben Carson
are you Uncle Ben the guy on converted rice box !!!!!!!!!!!!!
Sentiment: Strong Buy
WOW a ride on a $$$ 40 cent vical train ....................... Must be one lap around the circuit via a Lionel train set